[ad_1] Inheriting a 20-Year Legacy of Excellence and Innovation HONG KONG SAR – Media OutReach Newswire – 21 December 2023 – The 2023 Hang Lung Mathematics Awards (“HLMA”), co-organized by…
Tag: lung
Andre Braugher’s death highlights high risk of lung cancer in Black men
[ad_1] Pulmonologists have an important message for Black people: get screened for lung cancer. The Emmy award-winning actor Andre Braugher died last week at age 61 from lung cancer, just…
‘Brooklyn Nine-Nine’ actor Andre Braugher died from lung cancer, his rep said
[ad_1] “Brooklyn Nine-Nine” actor Andre Braugher died from lung cancer a few months after he was diagnosed with the disease, his representative said Thursday. The 61-year-old’s death was confirmed on…
Scientists discover how a key protein can stop spread of lung cancer
[ad_1] A new molecular pathway could help to stop the spread of lung cancer and help the development of new anti-cancer drugs. ADVERTISEMENT Researchers have identified a protein that could…
Sanofi looks to widen Dupixent use to treat ‘smoker’s lung’ after second trial win
[ad_1] The logo of French drugmaker Sanofi is seen a the Sanofi Genzyme Polyclonals in Lyon, France, September 30, 2023. REUTERS/Gonzalo Fuentes/File photo Acquire Licensing Rights Nov 27 (Reuters) –…
Mirati Therapeutics Receives Positive Opinion from CHMP for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation Following a Re-Examination Procedure
[ad_1] SAN DIEGO, Calif. and ZUG, Switzerland, Nov. 10, 2023 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced that following a re-examination procedure, the…
Ireland’s new forecast allows people to check their local air quality
[ad_1] The air quality forecast is especially important for people with asthma and heart conditions who are particularly vulnerable to pollution. ADVERTISEMENT Ireland has launched a new service that will…
Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
[ad_1] SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory…
GSK announces largest private financial contribution to CIHR’s Team Grants initiative addressing threats to Canadian lung health
[ad_1] GSK is investing $2 million in research to address ongoing, new, and emerging threats to lung health in Canada. Tweet this This investment will help interdisciplinary research teams better…
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients | BioSpace
[ad_1] SHANGHAI, Sept. 25, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services for patients with cancer…